WOCKPHARMA2019-04-012019-06-30in-bse-fin:OneOperatingExpenses01Member WOCKPHARMA2019-04-012019-06-30in-bse-fin:OneOperatingExpenses02Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares WOCKPHARMA 2019-04-01 2020-03-31 2019-07-22 INR Crores First quarter Single segment Pharmaceuticals 2019-04-01 2019-06-30 Unaudited Consolidated 8631100000.00 80800000.00 8711900000.00 1697900000.00 1546300000.00 283200000.00 2384000000.00 708900000.00 549600000.00 2320600000.00 9490500000.00 -778600000.00 0.00 -778600000.00 68700000.00 -478500000.00 -409800000.00 0.00 -368800000.00 0.00 0.00 0.00 0.00 -368800000.00 61500000.00 -307300000.00 -397400000.00 90100000.00 553500000.00 5 -4.06 -4.06 0.00 0.00 -4.06 -4.06 For Notes to Consolidated Results, please refer the Notes from the Statement of Consolidated Unaudited Results for the quarter ended June 30 2019 as attached which is submitted under Outcome of Board Meeting n Exchange fluctuation loss/ (gain),net 156700000.00 Other expenses 2163900000.00